121 related articles for article (PubMed ID: 17175376)
1. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.
Lee SJ; Kim KM; Chae MH; Lee WK; Kam S; Cha SI; Han HS; Kim CH; Kang YM; Han SB; Park JY
Cancer Genet Cytogenet; 2007 Jan; 172(1):29-32. PubMed ID: 17175376
[TBL] [Abstract][Full Text] [Related]
2. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
[TBL] [Abstract][Full Text] [Related]
4. Association of the EGFR intron 1 CA repeat length with lung cancer risk.
Zhang W; Weissfeld JL; Romkes M; Land SR; Grandis JR; Siegfried JM
Mol Carcinog; 2007 May; 46(5):372-80. PubMed ID: 17219440
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Taron M; Ichinose Y; Rosell R; Mok T; Massuti B; Zamora L; Mate JL; Manegold C; Ono M; Queralt C; Jahan T; Sanchez JJ; Sanchez-Ronco M; Hsue V; Jablons D; Sanchez JM; Moran T
Clin Cancer Res; 2005 Aug; 11(16):5878-85. PubMed ID: 16115929
[TBL] [Abstract][Full Text] [Related]
6. Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
Kharrat N; Al'Fadhli S; Rebaï A
J Recept Signal Transduct Res; 2008; 28(5):475-83. PubMed ID: 18946768
[TBL] [Abstract][Full Text] [Related]
7. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
8. Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor.
Chen B; Luo J; Gu W; Shen L; Wang H; Zhou S
Cell Biochem Biophys; 2015 Dec; 73(3):799-804. PubMed ID: 27259328
[TBL] [Abstract][Full Text] [Related]
9. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
Choi JE; Park SH; Kim KM; Lee WK; Kam S; Cha SI; Kim CH; Kang YM; Kim YC; Han SB; Jung TH; Park JY
BMC Cancer; 2007 Oct; 7():199. PubMed ID: 17956637
[TBL] [Abstract][Full Text] [Related]
13. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
14. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.
Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H
Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127
[TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
[TBL] [Abstract][Full Text] [Related]
16. EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissues.
Zhou Q; Cheung YB; Jada SR; Lim WT; Kuo WL; Gray JW; Lee AS; Chowbay B
Cancer Biol Ther; 2006 Nov; 5(11):1445-9. PubMed ID: 17102595
[TBL] [Abstract][Full Text] [Related]
17. An epidermal growth factor receptor intron 1 polymorphism in healthy women in Poland.
Bielawski KP; Klos P; Welnicka-Jaskiewicz M; Tidow M; Brandt B; Falkiewicz B; Zaczek A
Int J Biol Markers; 2005; 20(3):184-8. PubMed ID: 16240846
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status.
Han L; Lee CK; Pang H; Chan HT; Lo IL; Lam SK; Cheong TH; Ho JC
Lung Cancer; 2017 Dec; 114():79-89. PubMed ID: 29173771
[TBL] [Abstract][Full Text] [Related]
19. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
20. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis.
Lee EY; Yim JJ; Lee HS; Lee YJ; Lee EB; Song YW
Int J Immunogenet; 2006 Jun; 33(3):211-5. PubMed ID: 16712654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
